AJCC	American Joint Committee on Cancer
ASCO	American Society of Clinical Oncology
AUC	Area Under the Curve
CHOP	Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
CT	Computed Tomography
CTLA-4	Cytotoxic T-Lymphocyte Associated Protein-4
DLBCL	Diffuse Large B-Cell Lymphoma
EGFR	Epidermal Growth Factor Receptor
FAK	Focal Adhesion Kinase
FGF	Fibroblast Growth Factor
FOLFOX	5-Fluorouracil, Leucovorin, and Oxaliplatin
HITOC	Hyperthermic Intrathoracic Chemotherapy
ICIs	Immune Checkpoint Inhibitors
IPC	Indwelling Pleural Catheter
IV	Intravenously
LDCT	Low-Dose Computed Tomography
MPD	Malignant Pleural Disease
MPE	Malignant Pleural Effusion
MPM	Malignant Pleural Mesothelioma
MTD	Maximum Tolerated Dose
NSCLC	Non-Small Cell Lung Cancer
OS	Overall Survival
PDGFR-α	Platelet-Derived Growth Factor Receptor-Alpha
PD-L1	Programmed Death-Ligand 1
PEL	Primary Effusion Lymphoma
PET	Positron Emission Tomography
PFS	Progression-Free Survival
PITAC	Pressurized Intrathoracic Aerosol Chemotherapy
PLD	Pegylated Liposomal Doxorubicin
PMBCL	Primary Mediastinal Large B-Cell Lymphoma
RCT	Randomized Controlled Trial
SCLC	Small Cell Lung Cancer
TILs	Tumor-Infiltrating Lymphocytes
TNF-α	Tumor Necrosis Factor-Alpha
TNM	Tumor, Node, Metastasis
US	United States
VATS	Video-Assisted Thoracoscopic Surgery
VEGF	Vascular Endothelial Growth Factor
WHO	World Health Organization
XELOX	Capecitabine and Oxaliplatin